Back
Summary

BPC-157 is favored at 79% as of 28 Jul 2026, 18:33 UTC across 7 markets. Kalshi odds.

  • BPC-157: 79% (24h change 0%)
  • KPV: 79% (24h change 0%)
  • MOTS-c: 70% (24h change 0%)
  • Semax: 36% (24h change 0%)
  • Epitalon: 35% (24h change 0%)
  • Emideltide: 16% (24h change 0%)
  • TB-500: 12% (24h change 0%)
policy7 marketsLIVE

Which peptides will the FDA propose adding to the 503A Bulks List?

Trade ↗

All options

KPV

79%
Trade ↗